Detail publikace

Prostate cancer, miRNAs, metallothioneins and resistance to cytostatic drugs.

Originální název

Prostate cancer, miRNAs, metallothioneins and resistance to cytostatic drugs.

Anglický název

Prostate cancer, miRNAs, metallothioneins and resistance to cytostatic drugs.

Jazyk

en

Originální abstrakt

More surprising are the findings that levels of various miRNAs are well correlated with presence of specific tumours and formation of metastases. Moreover, these small regulatory molecules play a role in the resistance of cancer cells to commonly used anti-cancer drugs, such as cisplatin, anthracyclines, and taxanes. In that respect, miRNAs become very attractive target for potential therapeutic interventions

Anglický abstrakt

More surprising are the findings that levels of various miRNAs are well correlated with presence of specific tumours and formation of metastases. Moreover, these small regulatory molecules play a role in the resistance of cancer cells to commonly used anti-cancer drugs, such as cisplatin, anthracyclines, and taxanes. In that respect, miRNAs become very attractive target for potential therapeutic interventions

BibTex


@article{BUT98895,
  author="Vladimír {Pekařík} and Jaromír {Gumulec} and Michal {Masařík} and René {Kizek} and Vojtěch {Adam}",
  title="Prostate cancer, miRNAs, metallothioneins and resistance to cytostatic drugs.",
  annote="More surprising are the findings that levels of various miRNAs are well correlated with presence of specific tumours and formation of metastases. Moreover, these small regulatory molecules play a role in the resistance of cancer cells to commonly used anti-cancer drugs, such as cisplatin, anthracyclines, and taxanes. In that respect, miRNAs become very attractive target for potential therapeutic interventions",
  chapter="98895",
  number="4",
  volume="20",
  year="2013",
  month="january",
  pages="534--544",
  type="journal article in Web of Science"
}